Stock listing
BOATS:GRI GRI Bio, Inc. Stock
US listing (BOATS) of GRI Bio, Inc. · home listing NASDAQ:GRI
Follow GRI Bio, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:GRI
$1.53 USD -0.04 (-2.5%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:GRI
- Day range
- $1.45 – $1.59 USDOct 30, 2026
- Volume
- 28,212 sharesOct 30, 2026
- Market cap
- $3.34M USDAt the close on Oct 30, 2026 · price × 2.19M shares outstanding
- 52-week range
- $1.36 – $64.12 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $755,955 USDMedian day 51,900 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:GRI · Home | $1.53 USD | -0.04 (-2.5%) | 28,212 | $1.59 | $1.59 | $1.45 | $1.57 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:GRI · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.53 | -0.04 | -2.5% | $1.59 | $1.59 | $1.45 | 28,212 | |
| $1.57 | -0.055 | -3.4% | $1.60 | $1.65 | $1.57 | 21,991 | |
| $1.625 | +0.045 | +2.8% | $1.57 | $1.66 | $1.57 | 6,260 | |
| $1.58 | +0.08 | +5.3% | $1.51 | $1.629 | $1.487 | 33,197 | |
| $1.50 | +0.05 | +3.4% | $1.47 | $1.52 | $1.44 | 11,644 | |
| $1.45 | +0.03 | +2.1% | $1.45 | $1.53 | $1.422 | 64,900 | |
| $1.42 | -0.05 | -3.4% | $1.46 | $1.47 | $1.385 | 102,300 | |
| $1.47 | +0.01 | +0.7% | $1.58 | $1.58 | $1.46 | 59,000 | |
| $1.46 | +0.01 | +0.7% | $1.45 | $1.538 | $1.45 | 46,700 | |
| $1.45 | +0.07 | +5.1% | $1.37 | $1.50 | $1.36 | 42,600 | |
| $1.38 | -0.02 | -1.4% | $1.485 | $1.56 | $1.37 | 44,300 | |
| $1.40 | 0.00 | 0.0% | $1.43 | $1.45 | $1.38 | 28,500 | |
| $1.40 | -0.15 | -9.7% | $1.54 | $1.56 | $1.40 | 50,500 | |
| $1.55 | -0.02 | -1.3% | $1.60 | $1.60 | $1.52 | 28,900 | |
| $1.57 | -0.17 | -9.8% | $1.75 | $1.75 | $1.55 | 64,500 | |
| $1.74 | +0.06 | +3.6% | $1.71 | $1.76 | $1.70 | 21,300 | |
| $1.68 | -0.17 | -9.2% | $1.85 | $1.88 | $1.68 | 54,500 | |
| $1.85 | -0.05 | -2.6% | $1.88 | $1.92 | $1.85 | 31,500 | |
| $1.90 | -0.01 | -0.5% | $1.91 | $1.975 | $1.88 | 18,200 | |
| $1.91 | -0.05 | -2.6% | $2.04 | $2.04 | $1.88 | 84,600 | |
| $1.96 | 0.00 | 0.0% | $2.00 | $2.02 | $1.95 | 38,400 | |
| $1.96 | +0.03 | +1.6% | $1.93 | $1.97 | $1.91 | 20,300 | |
| $1.93 | -0.07 | -3.5% | $2.05 | $2.05 | $1.92 | 35,400 | |
| $2.00 | -0.10 | -4.8% | $2.09 | $2.106 | $2.00 | 25,600 | |
| $2.10 | +0.05 | +2.4% | $2.07 | $2.25 | $2.00 | 118,100 | |
| $2.05 | -0.04 | -1.9% | $2.07 | $2.08 | $1.95 | 53,300 | |
| $2.09 | -0.06 | -2.8% | $2.13 | $2.18 | $2.025 | 31,000 | |
| $2.15 | +0.10 | +4.9% | $2.05 | $2.19 | $1.95 | 143,400 | |
| $2.05 | +0.11 | +5.7% | $1.96 | $2.06 | $1.93 | 106,500 | |
| $1.94 | +0.01 | +0.5% | $2.00 | $2.19 | $1.85 | 260,800 | |
| $1.93 | +0.09 | +4.9% | $1.86 | $1.96 | $1.77 | 113,400 | |
| $1.84 | +0.03 | +1.7% | $1.77 | $1.91 | $1.72 | 174,200 | |
| $1.81 | -0.01 | -0.5% | $1.81 | $1.85 | $1.75 | 47,100 | |
| $1.82 | -0.07 | -3.7% | $1.89 | $1.89 | $1.80 | 69,300 | |
| $1.89 | -0.01 | -0.5% | $1.86 | $1.97 | $1.86 | 103,500 | |
| $1.90 | -0.04 | -2.1% | $1.99 | $2.05 | $1.85 | 131,700 | |
| $1.94 | +0.14 | +7.8% | $1.79 | $2.00 | $1.78 | 213,600 | |
| $1.80 | -0.20 | -10.0% | $1.97 | $1.97 | $1.76 | 199,500 | |
| $2.00 | -0.88 | -30.6% | $2.61 | $2.67 | $1.90 | 727,800 | |
| $2.88 | +0.59 | +25.8% | $2.34 | $3.36 | $2.33 | 7,464,800 | |
| $2.29 | +0.29 | +14.5% | $2.08 | $2.50 | $2.01 | 1,599,900 | |
| $2.00 | +0.09 | +4.7% | $1.92 | $2.02 | $1.87 | 85,800 | |
| $1.91 | -0.01 | -0.5% | $1.90 | $1.98 | $1.84 | 40,300 | |
| $1.92 | 0.00 | 0.0% | $1.93 | $1.97 | $1.86 | 43,000 | |
| $1.92 | -0.15 | -7.2% | $2.05 | $2.07 | $1.91 | 33,500 | |
| $2.07 | +0.16 | +8.4% | $1.821 | $2.10 | $1.821 | 78,500 | |
| $1.91 | -0.05 | -2.6% | $1.96 | $1.96 | $1.83 | 44,200 | |
| $1.96 | +0.17 | +9.5% | $1.80 | $1.98 | $1.785 | 126,500 | |
| $1.79 | +0.14 | +8.5% | $1.80 | $1.94 | $1.759 | 264,300 | |
| $1.65 | -0.02 | -1.2% | $1.71 | $1.73 | $1.65 | 83,100 | |
| $1.67 | -0.06 | -3.5% | $1.73 | $1.77 | $1.664 | 27,500 | |
| $1.73 | +0.02 | +1.2% | $1.75 | $1.793 | $1.69 | 61,600 | |
| $1.71 | -0.02 | -1.2% | $1.74 | $1.80 | $1.691 | 45,400 | |
| $1.73 | +0.06 | +3.6% | $1.67 | $1.75 | $1.61 | 56,800 | |
| $1.67 | -0.10 | -5.6% | $1.82 | $1.82 | $1.66 | 106,500 | |
| $1.77 | -0.18 | -9.2% | $1.90 | $1.90 | $1.71 | 184,200 | |
| $1.95 | -0.25 | -11.4% | $2.06 | $2.22 | $1.89 | 415,400 | |
| $2.20 | +0.50 | +29.4% | $1.86 | $2.55 | $1.75 | 6,540,600 | |
| $1.70 | +0.23 | +15.6% | $1.52 | $1.79 | $1.50 | 286,200 | |
| $1.47 | -0.08 | -5.2% | $1.55 | $1.55 | $1.41 | 32,600 | |
| $1.55 | +0.02 | +1.3% | $1.52 | $1.55 | $1.47 | 15,600 | |
| $1.53 | -0.06 | -3.8% | $1.60 | $1.61 | $1.53 | 22,400 | |
| $1.59 | +0.15 | +10.4% | $1.43 | $1.62 | $1.43 | 45,500 | |
| $1.44 | +0.06 | +4.3% | $1.45 | $1.47 | $1.42 | 22,000 | |
| $1.38 | -0.03 | -2.1% | $1.465 | $1.465 | $1.36 | 23,800 | |
| $1.41 | -0.06 | -4.1% | $1.48 | $1.49 | $1.39 | 27,700 |
- Ticker
- BOATS:GRI
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Sep 28, 2026
GRI Bio to Highlight Immune Modulation and Phase 2a Development Insights in IPF at the 10th IPF Summit
Latest deck · Sep 8, 2026
Investor Presentation (September 2026)
Investor deck · 21 slides
Latest news
GRI Bio to Highlight Immune Modulation and Phase 2a Development Insights in IPF at the 10th IPF Summit
Sep 28, 2026
Closed $2.10 (+2.4%) on Sep 28, 2026
GRI Bio Featured in "Why Now" On-Demand Video Webcast
Aug 27, 2026
Closed $2.07 (+8.4%) on Aug 27, 2026
GRI Bio to Present Late-Breaking Phase 2a GRI-0621 Data Highlighting Lung Function, Anti-Fibrotic Biomarkers and Favorable Tolerability in IPF at ERS 2026
Aug 24, 2026
Closed $1.79 (+8.5%) on Aug 24, 2026
GRI Bio Secures FDA Orphan Drug Designation for GRI-0621 (Tazarotene) in Idiopathic Pulmonary Fibrosis
Jun 18, 2026
Closed $1.88 (-19.0%) on Jun 18, 2026
GRI Bio to Present at A.G.P.’s Annual Healthcare Company Showcase
May 18, 2026
Closed $2.14 (+5.4%) on May 18, 2026
GRI Bio Receives Notice of Allowance for UAE Patent Application Covering Novel Type 2 Diverse NKT Cell Agonists for the Treatment of Inflammatory Conditions
Apr 8, 2026
Closed $2.40 (+4.3%) on Apr 8, 2026
GRI Bio CEO, Marc Hertz, Featured in Virtual Investor “What This Means” Segment
Feb 17, 2026
Closed $2.31 (0.0%) on Feb 17, 2026
GRI Bio to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial
Feb 5, 2026
Closed $2.19 (-17.0%) on Feb 5, 2026
GRI Bio Reiterates Full Year 2025 Financial Results, Strengthens Balance Sheet and Summarizes Key Recent Highlights
Feb 4, 2026
Closed $2.64 (+1.5%) on Feb 4, 2026
Decks
Investor Presentation (September 2026)
Investor deck · 21 slides · Sep 8, 2026
Investor Presentation (August 2025)
Investor deck · 23 slides · Aug 20, 2025
Investor Presentation (August 2024)
Investor deck · 25 slides · Aug 14, 2024
Investor Presentation (May 2024)
Investor deck · 25 slides · May 13, 2024
GRI Bio, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 16 in the last 12 months · 48 in all · newest Sep 28, 2026 · oldest 2021
- Decks
- 8 decks · latest Sep 8, 2026
Where GRI Bio, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:GRI · Home listing | NASDAQ | United States | USD |
| BOATS:GRI · This page | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about GRI Bio, Inc.